Interest Expense in USD of Kalaris Therapeutics, Inc. from Q1 2024 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Kalaris Therapeutics, Inc. quarterly Interest Expense history and change rate from Q1 2024 to Q1 2025.
Kalaris Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2025 was $1.44M, a 1750% increase year-over-year.

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Change (%)

Kalaris Therapeutics, Inc. Quarterly Interest Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2025		$1.44M	+$1.37M	+1750%	Jan 1, 2025	Mar 31, 2025	10-Q	2025-05-14
Q3 2024		$815K			Jul 1, 2024	Sep 30, 2024	10-Q	2025-11-12
Q2 2024		$499K			Apr 1, 2024	Jun 30, 2024	10-Q	2025-08-13
Q1 2024		$78K			Jan 1, 2024	Mar 31, 2024	10-Q	2025-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.